Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetesJūlı́us Guðmundsson, Theresa Graif, Þórunn Rafnar et al.|Nature Genetics|2007Cited by 725
Monosaccharides <i>versus</i> PEG-Functionalized NPs: Influence in the Cellular UptakeMaría Moros, Jesús M. de la Fuente, Bruno Hernáez et al.|ACS Nano|2012Cited by 151
Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of ActionIgnacio Durán, Oriol Casanovas, J. Lambea et al.|Targeted Oncology|2016Cited by 103